Washington | Reuters — Elanco Animal Health has won U.S. antitrust approval to buy Bayer’s animal health business on condition that it sell assets to treat three ailments, two in dogs and one in cattle, the Federal Trade Commission said on Wednesday. The deal was valued at $7.6 billion when it was announced in August […] Read more
Elanco Animal Health wins U.S. approval to buy Bayer unit
Elanco to shed cattle pour-on brand, others for approval
Elanco forgoes Canadian poultry insecticide rights for Bayer deal
Reuters — Elanco Animal Health has decided against acquiring Bayer’s Canadian distribution rights to several poultry insecticides, Canada’s Competition Bureau said on Tuesday, as it looks to complete a $7.6-billion deal. The U.S.-based company will also divest its canine ear infection treatment product Osurnia and Bayer’s feline dewormer Profender to address competition concerns about its […] Read more
Bayer puts Roundup future claims settlement on hold
Judge questions proposal for third-party scientists to rule on chemical's carcinogenicity
Frankfurt | Reuters — Bayer was forced on Wednesday to delay part of a proposed settlement of allegations that its widely used herbicide Roundup caused cancer after a U.S. judge questioned its plan to deal with future claims. The German company said that lawyers representing those preparing a class action had withdrawn a request for […] Read more
Bayer, Corteva among companies stepping off Facebook
Major firms pledge to pause advertising for July
A couple of major players in the agriculture sector are on an expanding list of major companies pausing advertising on Facebook for the month of July in pursuit of policy changes at the U.S.-based social media giant. Bayer and Corteva Agriscience recently announced they have joined the #stophateforprofit campaign, backed by organizations including the Anti-Defamation […] Read more
Investors pile into Bayer bond to pay settlement charges
Amsterdam | Reuters — Investors piled into a Bayer bond on Wednesday that will help pay for a long-negotiated settlement of U.S. lawsuits claiming its widely-used herbicide Roundup caused cancer. Demand for the four-tranche bond sale, whose proceeds will include the litigation payments, exceeded 17.5 billion euros, nearly three times the six billion euros (C$9.15 […] Read more
U.S. settlements not expected to change availability, labels for glyphosate, dicamba
Bayer to pay up to US$12 billion to resolve ag chem, PCB claims; company is "not contemplating" a Canadian glyphosate settlement
Updated, June 25 — Farmers in Canada, the U.S. and elsewhere shouldn’t expect any changes to availability or label directions for Bayer’s stable of glyphosate and dicamba herbicides, coming out of a massive settlement for thousands of lawsuits, the company says. The German company announced Wednesday it expects to spend up to $12 billion in […] Read more
Bayer reportedly near glyphosate settlement after lengthy talks
Proposed settlement said to include $2 billion for future cases
Reuters — Germany’s Bayer is set to reach a settlement this week with U.S. plaintiffs that claim its glyphosate-based herbicides cause cancer, two people familiar with the matter told Reuters. After more than a year of talks, however, some details and the overall amount of the settlement have yet to be finalised, one of the […] Read more
U.S. court blocks California cancer label on Roundup
WHO agency's ruling alone insufficient, judge says
Reuters — A U.S. federal appeals court on Monday blocked California from requiring that Bayer label its glyphosate-based herbicide Roundup with a cancer warning, handing the company a victory in its ongoing litigation over the product. In his ruling, U.S. District Judge William Shubb called California’s cancer warning misleading and said the state’s label is […] Read more
Bayer scraps plans for U.S. dicamba production
Move unrelated to court ruling, company says
Chicago | Reuters — Bayer said on Tuesday it will scrap a nearly US$1 billion project to produce dicamba in the United States, but said the move is unrelated to a federal court decision that blocked sales of dicamba-based herbicides. The German-based company is moving to save cash as it wages an expensive legal battle […] Read more
Elanco gets EU’s conditional antitrust OK for Bayer deal
Approval calls for sale of Vecoxan brand, among others
Reuters/Staff — Elanco Animal Health secured antitrust clearance on Monday from the European Union to buy Bayer’s veterinary drugs unit, after pledging to sell some products to address competition concerns about the US$7.6 billion deal. The European Commission said the companies will sell either Elanco or Bayer’s products or those in the pipeline, including licenses, […] Read more
Cyber-Savvy Farmer
